FN2 Earnings Intelligence
Medpace Holdings, Inc. financials (quarterly)
Medpace Holdings, Inc. (MEDP) Key Stats (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $441.4 | $46.3 | $285.4 | $652.7 | $502.7 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $558.6 | $603.3 | $659.9 | $706.6 | $707.3 |
| % Growth | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| EBITDA | $120.2 | $133.1 | $148.6 | $148.3 | $153.4 |
| % Margin | 21.5% | 22.1% | 22.5% | 21.0% | 21.7% |
| Net Income | $114.6 | $90.3 | $111.1 | $123.9 | $121.4 |
| % Margin | 20.5% | 15.0% | 16.8% | 17.5% | 17.2% |
| Diluted EPS | $3.67 | $3.10 | $3.86 | $4.28 | $4.25 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | $125.8 | - | - | $151.8 | - |
| CapEx | $10 | - | - | $6.8 | - |
| Free Cash Flow | $115.8 | - | - | $145 | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue | $558.6 | $603.3 | $659.9 | $706.6 | $707.3 |
| Gross Profit | - | - | - | - | - |
| EBITDA | $120.2 | $133.1 | $148.6 | $148.3 | $153.4 |
| Net Income | $114.6 | $90.3 | $111.1 | $123.9 | $121.4 |
| Diluted EPS | $3.67 | $3.10 | $3.86 | $4.28 | $4.25 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $441.4 | $46.3 | $285.4 | $652.7 | $502.7 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $125.8 | - | - | $151.8 | - |
| Capital Expenditure | $10 | - | - | $6.8 | - |
| Free Cash Flow | $115.8 | - | - | $145 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | 21.5% | 22.1% | 22.5% | 21.0% | 21.7% |
| Net Margin | 20.5% | 15.0% | 16.8% | 17.5% | 17.2% |
| FCF Margin | 20.7% | - | - | 20.5% | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the MEDP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.